Literature DB >> 17883400

Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells.

Julia C Fitzgerald1, Christoph Ufer, Luigi A De Girolamo, Hartmut Kuhn, E Ellen Billett.   

Abstract

Monoamine oxidases (MAOs) are mitochondrial enzymes which control the levels of neurotransmitters in the brain and dietary amines in peripheral tissues via oxidative deamination. MAO has also been implicated in cell signalling. In this study, we describe the MAO-A isoform as functional in apoptosis induced by staurosporine (STS) in human dopaminergic neuroblastoma cells (SH-SY5Y). Increased levels of MAO-A activity were induced by STS, accompanied by increased MAO-A protein and activation of the initiator of the intrinsic pathway, caspase 9, and the executioner caspase 3. MAO-A mRNA levels were unaffected by STS, suggesting that changes in MAO-A protein are due to post-transcriptional events. Two unrelated MAO-A inhibitors reduced caspase activation. STS treatment resulted in sustained activation of the mitogen-activated protein kinase pathway enzymes extracellular regulated kinase, c-jun terminal kinase and p38, and depletion of the anti-apoptotic protein Bcl-2. These changes were significantly reversed by MAO inhibition. Production of reactive oxygen species was increased following STS exposure, which was blocked by both MAO inhibition and the antioxidant N-acetylcysteine. Therefore our data provide evidence that MAO-A, through its production of reactive oxygen species as a by-product of its catalytic activity on the mitochondrial surface, is recruited by the cell to enhance apoptotic signalling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883400     DOI: 10.1111/j.1471-4159.2007.04921.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation.

Authors:  Zelan Wei; Tamara Satram-Maharaj; Bradley Chaharyn; Kelly Kuski; Paul R Pennington; Xia Cao; Jennifer Chlan; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2012-03-03       Impact factor: 3.575

Review 3.  Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-12-26       Impact factor: 3.575

4.  Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.

Authors:  Vedad Delic; Jeddidiah W D Griffin; Sandra Zivkovic; Yumeng Zhang; Tam-Anh Phan; Henry Gong; Dale Chaput; Christian Reynes; Vinh B Dinh; Josean Cruz; Eni Cvitkovic; Devon Placides; Ernide Frederic; Hamed Mirzaei; Stanley M Stevens; Umesh Jinwal; Daniel C Lee; Patrick C Bradshaw
Journal:  Neuromolecular Med       Date:  2017-06-15       Impact factor: 3.843

5.  Integration of light scattering with machine learning for label free cell detection.

Authors:  Wendy Yu Wan; Lina Liu; Xiaoxuan Liu; Wei Wang; Md Zahurul Islam; Chunhua Dong; Craig R Garen; Michael T Woodside; Manisha Gupta; Mrinal Mandal; Wojciech Rozmus; Ying Yin Tsui
Journal:  Biomed Opt Express       Date:  2021-05-19       Impact factor: 3.732

6.  Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms.

Authors:  Lina Chiuccariello; Sylvain Houle; Laura Miler; Robert G Cooke; Pablo M Rusjan; Grazyna Rajkowska; Robert D Levitan; Stephen J Kish; Nathan J Kolla; Xiaoming Ou; Alan A Wilson; Jeffrey H Meyer
Journal:  Neuropsychopharmacology       Date:  2013-10-24       Impact factor: 7.853

7.  Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells.

Authors:  Keiko Inaba-Hasegawa; Yukihiro Akao; Wakako Maruyama; Makoto Naoi
Journal:  J Neural Transm (Vienna)       Date:  2012-09-12       Impact factor: 3.575

8.  Mutagenic probes of the role of Ser209 on the cavity shaping loop of human monoamine oxidase A.

Authors:  Jin Wang; Johnny Harris; Darrell D Mousseau; Dale E Edmondson
Journal:  FEBS J       Date:  2009-07-23       Impact factor: 5.542

9.  Serotonin receptor 6 mediates defective brain development in monoamine oxidase A-deficient mouse embryos.

Authors:  Chi Chiu Wang; Gene Chi Wai Man; Ching Yan Chu; Astrid Borchert; Aslihan Ugun-Klusek; E Ellen Billett; Hartmut Kühn; Christoph Ufer
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

10.  Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.

Authors:  Paraskevi Vivien Rekkas; Alan A Wilson; Vivian Wai Han Lee; Priyanga Yogalingam; Julia Sacher; Pablo Rusjan; Sylvain Houle; Donna E Stewart; Nathan J Kolla; Stephen Kish; Lina Chiuccariello; Jeffrey H Meyer
Journal:  JAMA Psychiatry       Date:  2014-08       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.